U.S. Life Sciences Stock News

Dollar General recently prepared to report its fiscal 2027 second-quarter results, with analysts expecting earnings per share of US$2.00, up from US$1.86 in the same quarter a year earlier. An interesting aspect is that the retailer has exceeded analyst earnings forecasts in each of the past four quarters, which has increasingly shaped expectations around its ability to outperform projections. We’ll now examine how the company’s history of topping earnings estimates could influence Dollar...

Mercantile Bank Corporation recently reported its second-quarter and first-half 2026 results, showing higher net interest income and net income versus a year earlier, alongside increased basic and diluted earnings per share from continuing operations. The company also raised its quarterly dividend to US$0.4000 per share, signaling confidence in its earnings profile and capital position following the stronger half-year performance. Next, we’ll examine how this combination of stronger...

Recent share performance and business context Global Payments (GPN) has drawn fresh attention after a strong month for the stock, with the share price up about 20% over that period and roughly 24% over the past 3 months. Those moves come against a backdrop of reported annual revenue of US$8.86b and net income of US$630.19m, with both revenue and net income growth figures supplied as 13.02% and 46.77% respectively. See our latest analysis for Global Payments. Over a longer window the picture...

ePlus (PLUS) has asked shareholders to approve an increase in authorized common shares from 50,000,000 to 75,000,000 at its September 10, 2026 annual meeting, aiming to provide added flexibility in future financing. See our latest analysis for ePlus. The proposed increase in authorized shares comes as ePlus trades at US$89.10, with a 30-day share price return of 11.60% and a 1-year total shareholder return of 33.03%. Short-term momentum has picked up recently, while multi year total...

PACCAR Inc has released its second-quarter 2026 results, reporting sales of US$6,997.0 million and net income of US$752.0 million, alongside a regular quarterly cash dividend of US$0.35 per share payable on September 2, 2026. While quarterly sales edged only slightly higher year on year, earnings per share improved and first-half net income rose despite lower six-month sales, highlighting resilient profitability. With earnings per share ticking higher even as first-half sales softened, we’ll...

After a multi year surge that has left Amphenol shares up 329.8% over 5 years, the stock now screens as roughly in line with estimates of intrinsic value from a Discounted Cash Flow (DCF) model and with market based multiples. This raises the question of how much is already reflected in the current price. Over the past 5 years Amphenol has delivered a 329.8% return, which puts recent short term weakness into the context of a very strong longer run share price performance. The valuation case...

ADMA Biologics (ADMA) is under pressure after multiple securities class action lawsuits alleged undisclosed related party transactions, channel stuffing of ASCENIV inventory, and weak internal controls, following critical investigative reports and sharp stock price declines. See our latest analysis for ADMA Biologics. Recent lawsuits and investigative reports have followed a prolonged weak patch for ADMA Biologics, with the share price down 52.6% year to date and the 1 year total shareholder...

Baidu stock has delivered a decline of 36.8% over the past five years, yet current valuation checks do not clearly mark it out as a bargain. Recent news around a planned dual primary listing in Hong Kong and an artificial intelligence partnership in China has put Baidu back in focus for investors trying to square the long term share price record with today’s valuation signals. The share price is down 36.8% over five years, which raises questions about how much long term pessimism is already...

Perrigo (PRGO) has drawn investor attention after recent share performance metrics showed mixed short and longer term returns, prompting fresh questions about how its current US$10.14 price lines up with its fundamentals. See our latest analysis for Perrigo. At around US$10.14, Perrigo’s recent share price return over the past month has been slightly positive, although the year to date share price return and 1 year total shareholder return both show steep declines. This suggests momentum has...

Elastic (ESTC) is in focus after announcing that Jina AI models are now available through Jina On-Prem for on-premises and air-gapped environments, targeting customers with stricter data privacy and control requirements. See our latest analysis for Elastic. Against this backdrop, Elastic’s share price has been volatile, with a 1-day share price return of 4.36% and a 90-day share price return of 29.06%, while the 1-year total shareholder return declined 31.08%, suggesting short term momentum...

Marathon Petroleum’s shares have outperformed both the Oils-Energy sector and the S&P 500 in recent weeks, ahead of its now-completed August 4, 2026 earnings release that was expected to show a substantial year-over-year increase in earnings per share. This combination of strong recent performance and heightened attention on the company’s earnings outlook has sharpened focus on how analyst forecasts and revisions may reshape expectations for Marathon Petroleum’s longer-term prospects. We’ll...

MannKind stock has fallen 29.5% year to date, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market based valuation multiples currently point to the shares trading at a discount to their assessed worth. The near 30% year to date decline suggests sentiment has weakened, even as valuation models indicate potential upside from current levels. FDA approval of Furoscix ReadyFlow may support expectations for MannKind's future revenue, while the recent US$50...

Lumen Technologies has rewarded long term holders with a very large 249.7% gain over the past three years, yet its current checks send mixed signals, with a Discounted Cash Flow (DCF) estimate pointing to a premium price while market based multiples suggest the stock may still be inexpensive. The share price return of 249.7% over three years puts Lumen Technologies among the stronger performers in its sector. This naturally raises the bar for what counts as good value today. Recognition in a...

With the Federal Reserve reassessing how precisely it guides the market, interest rate expectations can swing more sharply, and that can ripple through bond portfolios, equity prices and household balance sheets. In this kind of stop start communication cycle, many investors look to low volatility dividend stocks that aim to combine steadier price moves with regular income. This article focuses on three stocks from a Low Volatility Dividend Stocks screener that appear closely exposed to these...

Palo Alto Networks (PANW) is back in focus after joining Nvidia’s new Open Secure AI Alliance, a broad industry effort to build open source tools for defending against AI powered cyberattacks. See our latest analysis for Palo Alto Networks. The AI alliance headlines arrive after a sharp run in Palo Alto Networks shares, with the 90 day share price return of 75.32% and 5 year total shareholder return of 375.60% pointing to strong longer term momentum despite recent weekly softness. If this AI...

Dana (DAN) has affirmed a quarterly dividend of US$0.1200 per share, payable on August 28, 2026. The ex dividend and record dates are both set for August 7, 2026, which places particular focus on income timing. See our latest analysis for Dana. At a share price of US$27.24, Dana has seen a 7 day share price return of 4.17% but a 90 day share price return that is down 27.61%, while the 1 year total shareholder return of 70.24% points to stronger longer term momentum. If Dana's mix of income...

In July 2026, Allegiant Travel Company announced a 12‑month exclusive partnership with Expedia Group, bringing Allegiant’s 566 nonstop routes across 124 U.S. cities to all Expedia U.S. brands as its first authorized online travel agency distributor. By adding Allegiant’s flights and achieving full coverage of U.S. commercial passenger airlines, Expedia Group strengthens its position as one of the most comprehensive travel marketplaces for domestic leisure travelers. Next, we’ll examine how...

In mid-July 2026, Wells Fargo & Company issued a series of new senior unsecured, callable notes across maturities from 2030 to 2046, while reporting second-quarter net interest income of US$12,317 million and net income of US$6,407 million, both higher than a year earlier. The bank also reported lower net loan charge-offs of US$876 million versus US$997 million a year ago, pointing to healthier credit quality alongside its expanded debt issuance. We’ll now examine how Wells Fargo’s stronger...

XPLR Infrastructure, LP has reported past second-quarter 2026 results, with sales rising to US$363 million while net income fell to US$38 million compared with the prior year. Despite weaker quarterly profit, the first half of 2026 marked a turnaround as the company moved from a US$19 million loss to a US$71 million profit. With the shares recently higher, we will examine how rising revenue but softer quarterly earnings shape XPLR Infrastructure’s broader investment narrative. This...

In recent days, investors have revisited Silgan Holdings after fresh analysis highlighted its earnings multiple, packaging mix, and industry positioning, prompting a reassessment of the business. The key issue now is whether Silgan’s competitive advantages and packaging volumes can support stronger margins or if current discounts reflect real pressure on demand and profitability. We’ll now examine how this renewed focus on Silgan’s earnings multiple and perceived undervaluation may reshape...

Forestar Group Inc. recently reported past third-quarter 2026 results, with sales of US$407.0 million and net income of US$35.9 million, alongside higher earnings per share than a year earlier. For the first nine months of the fiscal year, Forestar’s sales rose to US$1.05 billion and net income to US$83.5 million, while management kept full-year revenue guidance unchanged at US$1.60 billion to US$1.70 billion, signaling confidence in its existing outlook. Now, we’ll explore how this...

Rithm Capital Corp. has released its second-quarter 2026 results, reporting sales of US$236.69 million, net income of US$56.29 million, and basic and diluted earnings per share from continuing operations of US$0.04. The relatively modest earnings per share figure, alongside the update on profitability, gives investors fresh data to reassess expectations around Rithm Capital’s income-generating capacity and business mix. With Q2 2026 net income of US$56.29 million now public, we’ll examine...

Huron Consulting Group stock has delivered a 142.2% gain over the past 5 years, yet the broader valuation checks still suggest the shares may trade below what the fundamentals support. Over the last 5 years, a 142.2% total return indicates that long term holders have already seen strong value creation from Huron Consulting Group. The durability of Huron Consulting Group's advisory and consulting revenue can support valuations. However, any pressure on utilization rates or pricing may weigh...

AI infrastructure stocks sit at the crossroads of real world demand and the huge computing power that modern models require. While growth and inflation signals are mixed across major economies, capital spending on data centers, power and connectivity continues to be a key focus for many businesses and governments. This screener looks for the "picks and shovels" of AI, companies that turn that demand into revenue and cash flow. In this article you will see 3 stocks from the AI Infrastructure...